WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005061451) DIPHENYLAZETIDINONE DERIVATES PROCESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/061451    International Application No.:    PCT/SE2004/001959
Publication Date: 07.07.2005 International Filing Date: 21.12.2004
IPC:
C07D 205/08 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
ALENFALK, Susanne [SE/SE]; (SE) (For US Only).
DAHLSTRÖM, Mikael [FI/SE]; (SE) (For US Only).
HUNEGNAW, Fana [SE/SE]; (SE) (For US Only).
KARLSSON, Staffan [SE/SE]; (SE) (For US Only).
LEMURELL, Malin [SE/SE]; (SE) (For US Only).
LINDQVIST, Ann-Margret [SE/SE]; (SE) (For US Only).
SKJÄRET, Tore [NO/SE]; (SE) (For US Only).
STARKE, Ingemar [SE/SE]; (SE) (For US Only)
Inventors: ALENFALK, Susanne; (SE).
DAHLSTRÖM, Mikael; (SE).
HUNEGNAW, Fana; (SE).
KARLSSON, Staffan; (SE).
LEMURELL, Malin; (SE).
LINDQVIST, Ann-Margret; (SE).
SKJÄRET, Tore; (SE).
STARKE, Ingemar; (SE)
Agent: ASTRAZENECA; Global Intellectual Property, S-151 85 Södertälje (SE)
Priority Data:
0329778.5 23.12.2003 GB
Title (EN) DIPHENYLAZETIDINONE DERIVATES PROCESSING CHOLESTEROL ABSORPTION INHIBITORY ACTIVITY
(FR) DERIVES DIPHENYLAZETIDINONE PRESENTANT UNE ACTIVITE D'INHIBITION D'ABSORPTION DU CHOLESTEROL
Abstract: front page image
(EN)Compounds of formula (XV): [Chemical formula should be inserted here. Please see paper copy] (XV) (wherein variable groups are as defined within) pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia are described. Processes for their manufacture and pharmaceutical compositions containing them are also described.
(FR)L'invention concerne des composés de formule (XV) (dans laquelle de nombreux groupes sont spécifiés dans la description), ainsi que leurs sels pharmaceutiquement acceptables, des solvates, des solvates desdits sels et leurs promédicaments. L'invention concerne également leur utilisation en tant qu'inhibiteurs d'absorption du cholestérol dans le traitement de l'hyperlipidémie. L'invention concerne, en outre, des procédés de fabrication des composés ainsi que des compositions pharmaceutiques les contenant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)